279 related articles for article (PubMed ID: 18326020)
61. Prognostic significance of p53 immunohistochemical expression in adenoid cystic carcinoma of the salivary glands: a meta-analysis.
Li Q; Huang P; Zheng C; Wang J; Ge M
Oncotarget; 2017 Apr; 8(17):29458-29473. PubMed ID: 28206977
[TBL] [Abstract][Full Text] [Related]
62. C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 May; 95(5):586-93. PubMed ID: 12738950
[TBL] [Abstract][Full Text] [Related]
63. Expression of ER stress markers (GRP78/BiP and PERK) in adenoid cystic carcinoma.
Kaira K; Toyoda M; Shimizu A; Shino M; Sakakura K; Takayasu Y; Takahashi K; Asao T; Chikamatsu K
Acta Otolaryngol; 2016; 136(1):1-7. PubMed ID: 26366837
[TBL] [Abstract][Full Text] [Related]
64. EZH2 expression is a prognostic factor in childhood intracranial ependymoma: a Canadian Pediatric Brain Tumor Consortium study.
Li AM; Dunham C; Tabori U; Carret AS; McNeely PD; Johnston D; Lafay-Cousin L; Wilson B; Eisenstat DD; Jabado N; Zelcer S; Silva M; Scheinemann K; Fryer C; Hendson G; Fotovati A; Hawkins C; Yip S; Dunn SE; Hukin J
Cancer; 2015 May; 121(9):1499-507. PubMed ID: 25586788
[TBL] [Abstract][Full Text] [Related]
65. EZH2, Ki-67 and MCM7 are prognostic markers in prostatectomy treated patients.
Laitinen S; Martikainen PM; Tolonen T; Isola J; Tammela TL; Visakorpi T
Int J Cancer; 2008 Feb; 122(3):595-602. PubMed ID: 17943722
[TBL] [Abstract][Full Text] [Related]
66. Primary salivary gland-type lung cancer: clinicopathological analysis of 88 cases from China.
Zhu F; Liu Z; Hou Y; He D; Ge X; Bai C; Jiang L; Li S
J Thorac Oncol; 2013 Dec; 8(12):1578-84. PubMed ID: 24389442
[TBL] [Abstract][Full Text] [Related]
67. Enhancer of zeste homologue 2 expression in breast carcinoma smears in relationship with p53, Ki-67 and other prognostic parameters.
Athanassiadou AM; Tsipis A; Patsouris E; Gonidi M; Nicolopoulou-Stamati P; Chelidonis G; Athanassiadou P
Acta Cytol; 2011; 55(2):180-6. PubMed ID: 21325804
[TBL] [Abstract][Full Text] [Related]
68. Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.
Sasaki M; Matsubara T; Kakuda Y; Sato Y; Nakanuma Y
Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593
[TBL] [Abstract][Full Text] [Related]
69. High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
He LR; Liu MZ; Li BK; Jia WH; Zhang Y; Liao YJ; Chen YC; Zhang LJ; Guan XY; Zeng YX; Kung HF; Xie D
Int J Cancer; 2010 Jul; 127(1):138-47. PubMed ID: 19904743
[TBL] [Abstract][Full Text] [Related]
70. RASSF1A promoter hypermethylation is a strong biomarker of poor survival in patients with salivary adenoid cystic carcinoma in a Chinese population.
Zhang CY; Zhao YX; Xia RH; Han J; Wang BS; Tian Z; Wang LZ; Hu YH; Li J
PLoS One; 2014; 9(10):e110159. PubMed ID: 25302792
[TBL] [Abstract][Full Text] [Related]
71. Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma.
Cao W; Feng Z; Cui Z; Zhang C; Sun Z; Mao L; Chen W
Cancer; 2012 Jun; 118(11):2858-71. PubMed ID: 21989926
[TBL] [Abstract][Full Text] [Related]
72. Reappraisal of KIT mutation in adenoid cystic carcinomas of the salivary gland.
Sung JY; Ahn HK; Kwon JE; Jeong H; Baek CH; Son YI; Ahn YC; Park K; Ahn MJ; Ko YH
J Oral Pathol Med; 2012 May; 41(5):415-23. PubMed ID: 22077630
[TBL] [Abstract][Full Text] [Related]
73. Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma.
Sajed DP; Faquin WC; Carey C; Severson EA; H Afrogheh A; A Johnson C; Blacklow SC; Chau NG; Lin DT; Krane JF; Jo VY; Garcia JJ; Sholl LM; Aster JC
Am J Surg Pathol; 2017 Nov; 41(11):1473-1482. PubMed ID: 28914715
[TBL] [Abstract][Full Text] [Related]
74. Prognostic significance of Ki-67 in salivary gland carcinomas.
Larsen SR; Bjørndal K; Godballe C; Krogdahl A
J Oral Pathol Med; 2012 Sep; 41(8):598-602. PubMed ID: 22530699
[TBL] [Abstract][Full Text] [Related]
75. Aberrant differential expression of EZH1 and EZH2 in Polycomb repressive complex 2 among B- and T/NK-cell neoplasms.
Abdalkader L; Oka T; Takata K; Sato H; Murakami I; Otte AP; Yoshino T
Pathology; 2016 Aug; 48(5):467-82. PubMed ID: 27311868
[TBL] [Abstract][Full Text] [Related]
76. Differential expression of galectin-3, beta-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands.
Ferrazzo KL; Neto MM; dos Santos E; dos Santos Pinto D; de Sousa SO
J Oral Pathol Med; 2009 Oct; 38(9):701-7. PubMed ID: 19659475
[TBL] [Abstract][Full Text] [Related]
77. Adenoid cystic carcinoma of salivary and lacrimal gland origin: localization, classification, clinical pathological correlation, treatment results and long-term follow-up control in 84 patients.
Friedrich RE; Bleckmann V
Anticancer Res; 2003; 23(2A):931-40. PubMed ID: 12820326
[TBL] [Abstract][Full Text] [Related]
78. Expression of Autophagy and Reactive Oxygen Species-Related Proteins in Lacrimal Gland Adenoid Cystic Carcinoma.
Koo JS; Kim JW; Yoon JS
Yonsei Med J; 2016 Mar; 57(2):482-9. PubMed ID: 26847304
[TBL] [Abstract][Full Text] [Related]
79. Dedifferentiation in adenoid cystic carcinoma of salivary gland: an uncommon complication associated with an accelerated clinical course.
Cheuk W; Chan JK; Ngan RK
Am J Surg Pathol; 1999 Apr; 23(4):465-72. PubMed ID: 10199477
[TBL] [Abstract][Full Text] [Related]
80. MicroRNA dysregulation in adenoid cystic carcinoma of the salivary gland in relation to prognosis and gene fusion status: a cohort study.
Andreasen S; Tan Q; Agander TK; Hansen TVO; Steiner P; Bjørndal K; Høgdall E; Larsen SR; Erentaite D; Olsen CH; Ulhøi BP; Heegaard S; Wessel I; Homøe P
Virchows Arch; 2018 Sep; 473(3):329-340. PubMed ID: 30069755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]